Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1245/s10434-021-09766-6 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
International differences in the selection and outcome of minimally invasive and open distal pancreatectomy: A transatlantic analysis.
Surgery
March 2025
DGAV StuDoQ|Pancreas Registry and Clinic of Surgery, UKSH Campus Lübeck, Lübeck, Germany. Electronic address:
Pancreatic metastases are very rare tumors comprising 2-5 % of all malignant tumors of the pancreas. Colorectal pancreatic metastases are rare - 1.7%.
View Article and Find Full Text PDFPancreatic neuroendocrine tumors (PNETs) are uncommon cancers, but their overall incidence seems to be on the rise, possibly due to better detection with advancements in cross-sectional imaging techniques. This study consists of a retrospective analysis of PNET patients treated in the First Surgical Oncology Clinic over a period of 10 years. The patient files were evaluated, and the following parameters were taken into consideration: gender, age, primary tumor site, extension of the disease, metastatic sites, the therapeutic approach, type of surgery, histopathological results, postoperative mortality, and morbidity.
View Article and Find Full Text PDFRadical antegrade modular pancreatosplenectomy: Myth or reality? A systematic review and trial sequential meta-analysis.
Surgery
March 2025
Department of Internal Medicine and Surgery (DIMEC), Alma Mater Studiorum, University of Bologna, Italy; Division of Pancreatic Surgery, IRCCS Azienda Ospedaliero-Universitaria Di Bologna, Italy.
Background: The superiority of radical antegrade modular pancreatosplenectomy versus standard distal pancreatectomy has never been demonstrated.
Methods: A systematic review was performed to identify all comparative studies about radical antegrade modular pancreatosplenectomy versus standard distal pancreatectomy. Random-effects analysis was performed, and hazard ratios, odds ratios, and mean differences were calculated.
Robotic Central Pancreatectomy: Patient Selection and Surgical Approach.
Ann Surg Oncol
March 2025
Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Central pancreatectomy (CP) is one of the parenchyma-sparing approaches proposed for low-grade tumors. CP has a lower incidence of diabetes compared with distal pancreatectomy, but may harbor risks of positive distal pancreatic margin, inadequate lymph node (LN) removal, and pancreatic fistula from the pancreaticojejunal anastomosis. Given the reported oncologic safety, we selectively perform CP for small pancreatic neuroendocrine tumors (pNETs) that are localized to the pancreatic neck.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!